Financials
- Market Capitalization 7.58 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.15
Fiyat/satışlar oranı
-909.61
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4738 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.88 USD | -8.10% | -4.13% | +10.66% | +674.60% | 7.65 M USD | ||
| 4739 | SNGX Soligenix, Inc. - Common Stock | 0.35 USD | -2.78% | -2.78% | -5.41% | -69.03% | 7.62 M USD | ||
| 4746 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.36 USD | 0.00% | +1.49% | +5.43% | -36.15% | 7.47 M USD | ||
| 4748 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.64 USD | +8.47% | -4.48% | -16.88% | -57.62% | 8.06 M USD |